JosephRAragonMD

PubMed

• Early safety and efficacy of percutaneous left atrial appendage suture ligation: results from the U.S. transcatheter LAA ligation consortium.
  Price MJ, Gibson DN, Yakubov SJ, Schultz JC, Di Biase L, Natale A, Burkhardt JD, Pershad A, Byrne TJ, Gidney B, Aragon JR, Goldstein J, Moulton K, Patel T, Knight B, L...> ;J. Am. Coll. Cardiol.. 2014-08-12
• Comparison of sirolimus-, paclitaxel-, and everolimus-eluting stent in unprotected left main coronary artery percutaneous coronary intervention.
  Lee, M. S.,Mahmud, E.,Ang, L.,Lluri, G.,Cheng, R. K.,Aragon, J.,Sheiban, I.> ;J Saudi Heart Assoc. 2013 Nov 01
• Multicenter international registry of unprotected left main coronary artery percutaneous coronary intervention with everolimus-eluting stents.
  Lee MS, Park KW, Kang S, Sheiban I, Mahmud E, Thani KB, Cheng R, Cho J, Jin D, Gwon H, Chae I, Aragon J, Gillis K, Stone GW, Kim H> ;J Invasive Cardiol. 2012-07-01
• Pimecrolimus and dual pimecrolimus-paclitaxel eluting stents decrease neointimal proliferation in a porcine model.
  Berg R, Aragon J, Royter V, Shanley JF, Cogert G, Vermani R, Kar S, Eigler N, Litvack F> ;Catheter Cardiovasc Interv. 2007-11-15
• The effect of variable release kinetics on Paclitaxel efficacy from a drug eluting stent in a porcine model.
  Aragon, J.,Kar, S.,Tio, F.,Trauthen, B.,Parisky, A.,Watanabe, C.,Jamali, A.,Eigler, N.,Serruys, P. W.,Litvack, F.> ;EuroIntervention. 2005 Aug 01
• Comparison of frequency of left ventricular wall motion abnormalities in patients with a first acute myocardial infarction with versus without left ventricular hypertr...
  Neuman Y, Cercek B, Aragon J, Lee S, Kobal S, Miyamoto T, Luo H, Tolstrup K, Naqvi TZ, Birnbaum Y, Siegel RJ> ;Am. J. Cardiol.. 2004-09-15
• Intracoronary brachytherapy for in-stent restenosis of the left anterior descending artery via the left internal mammary artery using the galileo centering catheter.
  Aragon J, Litvak F> ;J Invasive Cardiol. 2004-03-01
• Coronary sinus is dilated and outwardly displaced in patients with mitral regurgitation: quantitative angiographic analysis.
  Lee, M. S., Shah, A. P., Dang, N., Berman, D., Forrester, J., Shah, P. K., Aragon, J., Jamal, F., Makkar, R. R.> ;Catheter Cardiovasc Interv. 2006 Mar
• Drug-eluting stenting is superior to bare metal stenting in saphenous vein grafts.
  Lee, M. S., Shah, A. P., Aragon, J., Jamali, A., Dohad, S., Kar, S., Makkar, R. R.> ;Catheter Cardiovasc Interv. 2005 Dec
• Comparison of sirolimus-eluting stents with paclitaxel-eluting stents in saphenous vein graft intervention (from a multicenter Southern California Registry).
  Lee, M. S., Hu, P. P., Aragon, J., Shah, A. P., Oyama, J., Dhoot, J., Iqbal, Z., Jones, N., Penny, W., Tobis, J., Mahmud, E., French, W.> ;Am J Cardiol. 2010 Aug 1
• Stent fracture associated with drug-eluting stents: clinical characteristics and implications.
  Lee, M. S., Jurewitz, D., Aragon, J., Forrester, J., Makkar, R. R., Kar, S.> ;Catheter Cardiovasc Interv. 2007 Feb 15
• Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease.
  Lee, M. S., Kapoor, N., Jamal, F., Czer, L., Aragon, J., Forrester, J., Kar, S., Dohad, S., Kass, R., Eigler, N., Trento, A., Shah, P. K., Makkar, R. R.> ;J Am Coll Cardiol. 2006 Feb 21
• Percutaneous left ventricular assist device: "TandemHeart" for high-risk coronary intervention.
  Aragon, J., Lee, M. S., Kar, S., Makkar, R. R.> ;Catheter Cardiovasc Interv. 2005 Jul
• Long-term outcomes of elective drug-eluting stenting of the unprotected left main coronary artery in patients with normal left ventricular function.
  Lee, M. S., Yang, T., Biondi-Zoccai, G., Sillano, D., Cerrato, E., Tarantini, G., Xhaxho, J., Aragon, J., Sheiban, I.> ;Catheter Cardiovasc Interv. 2011 Jun 1
• Impact of chronic renal insufficiency on clinical outcomes in patients undergoing saphenous vein graft intervention with drug-eluting stents: a multicenter Southern Ca...
  Lee, M. S., Hu, P. P., Aragon, J., Shah, A., Bhatia, R., Jones, N., Penny, W., French, W., Tobis, J., Mahmud, E.> ;Catheter Cardiovasc Interv. 2010 Aug 1
• New heparin dosing regimen for diabetics undergoing percutaneous coronary intervention.
  Lee, M. S., Rametta, S., Aragon, J., Khan, A., Wilentz, J., Singh, V., Levitt, H., Kamra, A., Valania, G., Makkar, R.> ;J Invasive Cardiol. 2005 May
• Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial.
  Price, M. J., Berger, P. B., Teirstein, P. S., Tanguay, J. F., Angiolillo, D. J., Spriggs, D., Puri, S., Robbins, M., Garratt, K. N., Bertrand, O. F., Stillabower, M. ...> ;JAMA. 2011 Mar 16
• Join now to see all